BridgeBio Pharma, Inc. ( BBIO) - Stock Earnings
BBIO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q1 | -167.4 million USD | 116.6 million USD |
| 2024Q4 | -265.1 million USD | 5.9 million USD |
| 2024Q3 | -162.0 million USD | 2.7 million USD |
| 2024Q2 | -73.5 million USD | 2.2 million USD |
| 2024Q1 | -35.2 million USD | 211.1 million USD |
BBIO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | -535.8 million USD | 221.9 million USD |
| 2023 | -643.2 million USD | 9.3 million USD |
| 2022 | -494.0 million USD | 77.6 million USD |
| 2021 | -639.3 million USD | 69.7 million USD |
| 2020 | -483.9 million USD | 8.2 million USD |
BBIO
Price: $40
52 week price:
Payout Ratio Range:
Earnings Per Share: -3.56 USD
P/E Ratio: -10.74
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 1.7 million
Market Capitalization: 7.3 billion